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Abstract
We report the ﬁrst case of fatal spontaneous bacterial peritonitis
and fulminant hepatitis caused by Nocardia cyriacigeorgica in a
patient with hepatitis C-related liver cirrhosis.
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Case Report
Spontaneous bacterial peritonitis (SBP) caused by Nocardia spp.
is rare. We present the ﬁrst case of fatal SBP from Nocardia
cyriacigeorgica in a patient with liver cirrhosis related to
hepatitis C virus infection.
A 59-year-old male presented with 2 weeks of non-colicky
abdominal pain refractory to empiric treatment of SBP with
oral ciproﬂoxacin by a primary-care practitioner. Hepatitis C
virus infection was diagnosed 3 years previously and he had
failed pegylated interferon/ribavirin and subsequently boce-
previr + interferon/ribavirin treatment. Resultant complica-
tions included compensated cirrhosis with portal
hypertension, oesophageal varices and a previous episode of
culture-negative SBP. Co-morbidities included chronic
obstructive pulmonary disease not on systemic corticoster-
oids. He denied active intravenous drug use or alcohol
consumption.
Salient clinical ﬁndings included fever (38.5°C), tachycardia
(120 beats/min), hypotension (90/50 mmHg) and tense ascites.
No pulmonary ﬁndings or cutaneous lesions were noted.
Paracentesis on admission revealed turbid ﬂuid with white cell
count of 10 800 9 106/L (66% neutrophils, 34% mononuclear
cells). Pending further cultures, broad-spectrum intravenous
antibiotics (cefepime, amoxicillin and metronidazole) for septic
shock were commenced. In the following 24 h, despite
intensive organ support, he deteriorated with ensuing fulmin-
ant liver failure. Initial and subsequent computed tomographic
scans of his abdomen are shown in Fig. 1. After 48 h,
incubated ascitic ﬂuid cultures ﬂagged positive and microscopy
revealed branching Gram-positive bacilli. Nocardia spp. was
suspected and treatment was changed to amikacin 1500 mg
daily and meropenem 2 g twice daily. Cultures from a second
paracentesis conﬁrmed the same organism. The patient died
from multiorgan failure 72 h after admission.
Further sub-cultures after death conﬁrmed pure growth of
white dry crumbly colonies consistent with Nocardia species.
16S ribosomal RNA gene sequencing of a 745-base-pair PCR
product demonstrated 100% homology with a Nocardia
cyriacigeorgica reference strain in the GenBank database
(accession numbers NR_074699 and NR_041857).
Nocardiae are ubiquitous Gram-positive aerobic actinomy-
cetes [1,2]. Primary infections commonly present as pulmo-
nary or cutaneous diseases but immunocompromised patients
are vulnerable to secondary disseminated infections. Nocardia
cyriacigeorgica was recently deﬁned as a distinct species based
on 16S rRNA gene sequences and displays susceptibility to
trimethoprim-sulfamethoxazole, third- and fourth-generation
cephalosporins, amikacin, imipenem and linezolid but resis-
tance to penicillins, clarithromycin and ciproﬂoxacin (Nocardia
asteroides type VI susceptibility pattern) [1,3]. Nocardia cyriac-
igeorgica infections were previously reported in patients with
septicaemia, brain abscess, pleural empyema and endocarditis
[1]. This is the ﬁrst case of N. cyriacigeorgica SBP to our
knowledge. Other reports of Nocardia spp. peritonitis are
caused by other species and have only been described
following iatrogenic surgical procedures or secondary dissem-
ination [4–7].
We hypothesized that without other clinically identiﬁable
primary focus, our patient had primary SBP from N. cyriaci-
georgica. The pathogenesis of SBP in cirrhosis is due to
translocation of microorganisms from the intestinal lumen to
the peritoneal cavity via the portal venous system, facilitated by
impaired immunity and increased permeability from splanchnic
vasodilation [8]. Nocardia probably entered the peritoneum
through ingestion of contaminated food and evasion of host
defences.
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Recommended empiric antibiotic regimens for severe
nocardiosis include trimethoprim-sulfamethoxazole and ami-
kacin or carbapenem and amikacin as these combinations have
activity against almost all species of Nocardia [2,3].
Although rare, Nocardia spp. need to be considered as a
cause of SBP, especially in immunocompromised patients who
fail to respond to standard treatment and when the routine
bacteriological cultures are negative.
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(a) (b)
FIG. 1. (a) Computed tomography (CT) of abdomen on admission showing oedematous liver with diffuse hypoperfusion, ascites (arrows) and
porto-systemic varices (arrowhead). (b) CT of abdomen 48 h after admission showing progressive changes in liver (arrows) despite normal
enhancement of portal vessels.
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